The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot study of nivolumab in pediatric patients with hypermutant cancers.
 
Daniel A. Morgenstern
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Clarity Pharmaceuticals; EUSA Pharma; Roche; Ymabs Therapeutics Inc
Speakers' Bureau - Ymabs Therapeutics Inc
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
Natalie Bucheimer Collins
No Relationships to Disclose
 
Rebecca Deyell
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Rina Dvir
No Relationships to Disclose
 
Melissa Edwards
No Relationships to Disclose
 
Cecile Faure-Conter
No Relationships to Disclose
 
Timothy E. Hassall
No Relationships to Disclose
 
Lauren Sambira
Research Funding - Bristol-Myers Squibb (Inst)
 
Emily L. Taylor
Research Funding - Bristol-Myers Squibb (Inst)
 
Uri Tabori
No Relationships to Disclose
 
Eric Bouffet
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)